While clinical lab product revenues were flat year over year, point-of-care sales spiked 29 percent on higher HIV test sales in Africa.
The company said that the decline in revenues reflected lower industry-wide reimbursement rates under PAMA.
Having recently won prequalification status from the World Health Organization the British Columbia-based firm is also considering US regulatory options.
Investigators at the Foundation for Research and Technology - Hellas, a Greek research institute, are coordinating the effort.
Ascend Clinical Laboratory said it replaced its existing Siemens analyzers with the Atellica to manage growth, including during periods of high demand.
The SuperExtract 32 with the SuperExtract Viral Mag NA Purification kit provides high-quality purification of hepatitis and HIV viral nucleic acid.
The firm said revenues fell because of delayed shipments of HIV self-tests and ongoing softness in the consumer genomics markets.
The research team said its nanofluidic system increased the proportion of nucleic acid and protein disease biomarkers a billionfold prior to detection.
The program started in 2014, originally to increase access to HIV diagnostics, and provides special pricing to qualifying organizations in eligible countries.
The study compared a variety of serological tests for visceral leishmaniasis that are available in Brazil, a hotspot for the parasitic disease.